Mohammad Jahanzeb

Mohammad Jahanzeb

UNVERIFIED PROFILE

Are you Mohammad Jahanzeb?   Register this Author

Register author
Mohammad Jahanzeb

Mohammad Jahanzeb

Publications by authors named "Mohammad Jahanzeb"

Are you Mohammad Jahanzeb?   Register this Author

54Publications

1177Reads

39Profile Views

Update on Precision Medicine in Breast Cancer.

Cancer Treat Res 2019 ;178:45-80

Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-030-16391-4_2DOI Listing
June 2019

Use of Patient-Reported Outcome Measures in Quality Oncology Practice Initiative-Registered Practices: Results of a National Survey.

J Oncol Pract 2018 10 12;14(10):e602-e611. Epub 2018 Sep 12.

Harvard Medical School; Dana-Farber Cancer Institute, Boston, MA; American Society of Clinical Oncology, Washington, DC; University of Miami, Deerfield Beach, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00088DOI Listing
October 2018

Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab.

Clin Lung Cancer 2018 05 21;19(3):280-288.e4. Epub 2017 Dec 21.

Divisions of Hematology and Medical Oncology, Departments of Medicine, Miller School of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.12.007DOI Listing
May 2018

Choosing Wisely in Oncology: Are We Ready For Value-Based Care?

J Oncol Pract 2017 11 7;13(11):e935-e943. Epub 2017 Aug 7.

University of Alabama at Birmingham, Birmingham, AL; Stanford University Cancer Institute, Stanford; UCLA/Veterans Affairs, Los Angeles, CA; University of Miami, Miami; University of Florida, Gainesville, FL; ASCO, Alexandria, VA; MD Anderson Cancer Center at Cooper, Voorhees Township, NJ; and University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.019281DOI Listing
November 2017

Patient with typical carcinoid initially diagnosed as high-grade neuroendocrine carcinoma.

Lung Cancer Manag 2017 Nov 26;6(2):41-45. Epub 2017 Oct 26.

Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 1192 East Newport Center Drive, Suite 100, Deerfield Beach, FL 33442-7753, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/lmt-2017-0010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310322PMC
November 2017

The End of Nihilism: Systemic Therapy of Advanced Non-Small Cell Lung Cancer.

Annu Rev Med 2017 01 7;68:153-168. Epub 2016 Sep 7.

Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Deerfield Beach, Florida 33442; email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev-med-042915-102442DOI Listing
January 2017

Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline.

J Clin Oncol 2016 09 23;34(25):3069-103. Epub 2016 May 23.

Hope S. Rugo, University of California San Francisco Comprehensive Cancer Center; Barbara Fowble, University of California San Francisco, San Francisco; Rita S. Mehta, University of California Irvine, Orange, CA; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria; James L. Khatcheressian, Virginia Cancer Institute, Richmond, VA; Erin Macrae, Columbus Oncology and Hematology Associates, Columbus, OH; Debra L. Barton, University of Michigan School of Nursing, Ann Arbor, MI; Hannah Klein Connolly, Patient Representative, Edina, MN; Maura N. Dickler, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Lesley Fallowfield, Sussex Health Outcomes Research and Education in Cancer, Brighton and Sussex Medical School, University of Sussex, Sussex; Stephen R.D. Johnston, Royal Marsden Hospital, London, United Kingdom; James N. Ingle, Mayo Clinic, Rochester, MN; Mohammad Jahanzeb, University of Miami Sylvester Comprehensive Cancer Center, Deerfield Beach, FL; Larissa A. Korde, University of Washington, Seattle, WA; Hyman B. Muss, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; and Harold J. Burstein, Dana-Farber Cancer Center, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.1487DOI Listing
September 2016

Effectiveness of bevacizumab exposure beyond disease progression in patients with non-small-cell lung cancer: analyses of the ARIES observational cohort study.

Pharmacoepidemiol Drug Saf 2016 05 8;25(5):569-77. Epub 2016 Jan 8.

Department of Oncology, Yale Cancer Center and Smilow Cancer Hospital, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.3948DOI Listing
May 2016

Use of Cytotoxic Chemotherapy in Metastatic Breast Cancer: Putting Taxanes in Perspective.

Clin Breast Cancer 2016 Apr 25;16(2):73-81. Epub 2015 Sep 25.

Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Deerfield Beach, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2015.09.007DOI Listing
April 2016

Safety and effectiveness of bevacizumab-containing treatment for non-small-cell lung cancer: final results of the ARIES observational cohort study.

J Thorac Oncol 2014 Sep;9(9):1332-9

*Yale Cancer Center and Smilow Cancer Hospital, New Haven, Connecticut; †Sarah Cannon Research Institute and Tennessee Oncology, PLLC, Nashville, Tennessee; ‡Department of Oncology, Johns Hopkins Medical School, Baltimore, Maryland; §Oncology Associates of Bridgeport, PC, Trumbull, Connecticut; ‖Duke University Health Systems, Durham, North Carolina; ¶The University of Miami Sylvester Cancer Center, Deerfield Beach, Florida; #University of Minnesota, Minneapolis, Minnesota; **National Lung Cancer Partnership, Madison, Wisconsin; ††Karmanos Cancer Institute, Detroit, Michigan; ‡‡Genentech, Inc., South San Francisco, California; and §§Scripps Clinic, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000257DOI Listing
September 2014

Southwest Oncology Group S0802: a randomized, phase II trial of weekly topotecan with and without ziv-aflibercept in patients with platinum-treated small-cell lung cancer.

J Clin Oncol 2014 Aug 7;32(23):2463-70. Epub 2014 Jul 7.

Jeffrey W. Allen, University of Tennessee Health Science Center, Memphis, TN; James Moon, Mary Redman, Southwest Oncology Group Statistical Center, Seattle, WA; Shirish M. Gadgeel, Karmanos Cancer Institute, Wayne State University, Detroit, MI; Karen Kelly, Phillip C. Mack, David R. Gandara, University of California Davis Cancer Center, Sacramento, CA; Hanna M. Saba, Central Illinois CCOP/Cancer Care Specialists of Central Illinois, Effingham, IL; Mohamed K. Mohamed, Moses Cone Health System, Greensboro, NC; and Mohammad Jahanzeb, University of Miami, Miami, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.4109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121504PMC
August 2014

Blockade of the HER family of receptors in the treatment of HER2-positive metastatic breast cancer.

Clin Breast Cancer 2012 Feb 8;12(1):19-29. Epub 2011 Sep 8.

University of Tennessee Cancer Institute, Memphis, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2011.07.001DOI Listing
February 2012

The potential application of zoledronic acid as anticancer therapy in patients with non-small-cell lung cancer.

Clin Lung Cancer 2011 Jan;12(1):26-32

Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami Health Systems, Deerfield Beach, FL 33442, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2011.n.003DOI Listing
January 2011

Bisphosphonates as anticancer therapy for early breast cancer.

Clin Breast Cancer 2010 Oct;10(5):359-66

University of Miami, Deerfield Beach, FL 33442, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2010.n.047DOI Listing
October 2010

The Abu Dhabi declaration: why the hustle?

J Natl Compr Canc Netw 2010 Jul;8 Suppl 3:S2-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2010.0119DOI Listing
July 2010

The process of NCCN guidelines adaptation to the Middle East and North Africa region.

J Natl Compr Canc Netw 2010 Jul;8 Suppl 3:S5-7

Department of Oncology, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2010.0125DOI Listing
July 2010

Bisphosphonates in lung cancer: more than a palliative therapy?

Semin Oncol 2010 Jun;37 Suppl 1:S45-52

Boca Raton Comprehensive Cancer Center, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2010.06.004DOI Listing
June 2010

Does race affect outcomes in triple negative breast cancer?

Breast Cancer (Auckl) 2010 May 7;4:23-33. Epub 2010 May 7.

University of Tennessee Health Science Center Memphis, TN.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914275PMC
May 2010

Continuing trastuzumab beyond progression.

J Clin Oncol 2009 Apr 16;27(12):1935-7. Epub 2009 Mar 16.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2008.20.8215
Publisher Site
http://dx.doi.org/10.1200/JCO.2008.20.8215DOI Listing
April 2009

Evolution of bevacizumab-based therapy in the management of breast cancer.

Clin Breast Cancer 2008 Oct;8(5):402-10

University of Tennessee College of Medicine, Memphis, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2008.n.048DOI Listing
October 2008

Extensive-stage small-cell lung cancer: evolution of systemic therapy and future directions.

Clin Lung Cancer 2008 Sep;9(5):262-70

University of Tennessee Cancer Institute, Memphis, TN 38104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2008.n.041DOI Listing
September 2008

Adjuvant trastuzumab therapy for HER2-positive breast cancer.

Clin Breast Cancer 2008 Aug;8(4):324-33

Aptium Oncology, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2008.n.037DOI Listing
August 2008

Neoadjuvant chemotherapy in stage III NSCLC.

J Natl Compr Canc Netw 2008 Mar;6(3):285-93

University of Tennessee Cancer Institute, Memphis, Tennessee, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2008.0024DOI Listing
March 2008

Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.

Clin Ther 2007 Aug;29(8):1535-47

Division of Hematology-Oncology, University of Tennessee College of Medicine, Memphis, Tennessee 38104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2007.08.013DOI Listing
August 2007

A process for measuring the quality of cancer care: the Quality Oncology Practice Initiative.

J Clin Oncol 2005 Sep 8;23(25):6233-9. Epub 2005 Aug 8.

Oncology Hematology Care, 4725 E Galbraith, Suite 320, Cincinnati, OH 45236, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.05.948DOI Listing
September 2005

Docetaxel and carboplatin as first-line therapy in advanced non-small cell lung carcinoma: a phase II study.

Anticancer Res 2004 Mar-Apr;24(2C):1239-42

University of Tennessee Cancer Institute, 1331 Union Avenue-Suite 800, Memphis, TN 38104, USA.

View Article

Download full-text PDF

Source
June 2004

Trastuzumab-based combinations in metastatic breast cancer: how to make a choice.

Clin Breast Cancer 2003 Apr;4(1):28-38

Division of Hematology-Oncology, University of Tennessee College of Medicine, Memphis 38104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/cbc.2003.n.009DOI Listing
April 2003